JOWELL GLOBAL LTD (JWEL)

KYG5194C1197 - Common Stock

2.66  -0.15 (-5.34%)

Fundamental Rating

2

JWEL gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 121 industry peers in the Specialty Retail industry. The financial health of JWEL is average, but there are quite some concerns on its profitability. JWEL does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

JWEL had negative earnings in the past year.
JWEL had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: JWEL reported negative net income in multiple years.
JWEL had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -32.49%, JWEL is doing worse than 90.00% of the companies in the same industry.
JWEL has a worse Return On Equity (-45.50%) than 70.00% of its industry peers.
Industry RankSector Rank
ROA -32.49%
ROE -45.5%
ROIC N/A
ROA(3y)-19.85%
ROA(5y)-7.65%
ROE(3y)-30.78%
ROE(5y)-9.14%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

JWEL has a worse Gross Margin (2.04%) than 96.67% of its industry peers.
JWEL's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for JWEL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-42.65%
GM growth 5Y-34.16%

6

2. Health

2.1 Basic Checks

JWEL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, JWEL has more shares outstanding
JWEL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, JWEL has an improved debt to assets ratio.

2.2 Solvency

JWEL has an Altman-Z score of 3.46. This indicates that JWEL is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of JWEL (3.46) is better than 77.50% of its industry peers.
JWEL has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
JWEL has a Debt to Equity ratio of 0.02. This is in the better half of the industry: JWEL outperforms 73.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 3.46
ROIC/WACCN/A
WACC8.52%

2.3 Liquidity

A Current Ratio of 2.95 indicates that JWEL has no problem at all paying its short term obligations.
The Current ratio of JWEL (2.95) is better than 91.67% of its industry peers.
JWEL has a Quick Ratio of 2.04. This indicates that JWEL is financially healthy and has no problem in meeting its short term obligations.
JWEL's Quick ratio of 2.04 is amongst the best of the industry. JWEL outperforms 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.95
Quick Ratio 2.04

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.91% over the past year.
Looking at the last year, JWEL shows a very negative growth in Revenue. The Revenue has decreased by -23.81% in the last year.
Measured over the past years, JWEL shows a very strong growth in Revenue. The Revenue has been growing by 45.90% on average per year.
EPS 1Y (TTM)16.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.55%
Revenue 1Y (TTM)-23.81%
Revenue growth 3Y18.2%
Revenue growth 5Y45.9%
Sales Q2Q%-31.02%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JWEL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

JWEL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

JOWELL GLOBAL LTD

NASDAQ:JWEL (12/23/2024, 6:09:09 PM)

2.66

-0.15 (-5.34%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)09-29 2022-09-29/amc
Earnings (Next)N/A N/A
Inst Owners0.71%
Inst Owner Change-58.98%
Ins Owners0.34%
Ins Owner ChangeN/A
Market Cap5.77M
Analysts0
Price TargetN/A
Short Float %3.45%
Short Ratio0.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B 0.23
P/tB 0.23
EV/EBITDA N/A
EPS(TTM)-5.36
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-6.23
FCFYN/A
OCF(TTM)-6.22
OCFYN/A
SpS73.74
BVpS11.61
TBVpS11.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -32.49%
ROE -45.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 2.04%
FCFM N/A
ROA(3y)-19.85%
ROA(5y)-7.65%
ROE(3y)-30.78%
ROE(5y)-9.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-42.65%
GM growth 5Y-34.16%
F-Score3
Asset Turnover4.53
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.53%
Cap/Sales 0.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.95
Quick Ratio 2.04
Altman-Z 3.46
F-Score3
WACC8.52%
ROIC/WACCN/A
Cap/Depr(3y)307.71%
Cap/Depr(5y)234.62%
Cap/Sales(3y)0.42%
Cap/Sales(5y)0.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.55%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-23.81%
Revenue growth 3Y18.2%
Revenue growth 5Y45.9%
Sales Q2Q%-31.02%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.53%
OCF growth 3YN/A
OCF growth 5YN/A